FIELD: organic chemistry, heterocyclic compounds.
SUBSTANCE: invention relates to derivatives of purine eliciting an antiviral activity with respect to human cytomegalovirus and human immunodeficiency virus type-1 of the general formula (I): wherein n = 0-4; m = 0-3; R1 means hydrogen atom, hydroxyl or NH2-group; R2 means hydroxyl, NH2-group, acetylamino-group or benzoylamino-group; R3 means hydrogen atom or lower (C1-C4)-alkyl; R4 means hydrogen atom, lower (C1-C4)-alkyl or phenyl; X means CH, oxygen atom, NH or C(O)O; Y means CH2, CH=CH, C(O), oxygen atom or a simple bond; Ar means phenyl, pyridyl, naphthyl or substituted phenyl of the formula: wherein R5-R9 mean independently (C1-C8)-alkyl, (C5-C6)-cycloalkyl, 1-adamantyl, allyl, phenyl, benzyl, fluorine, chlorine, bromine, iodine atom, trifluoromethyl group, (C1-C5)-alkoxy-group, phenoxy-group, benzyloxy-group, cyano-group, carboxy-group, acetyl or nitro-group. Antiviral effect of the most active substances with respect to human cytomegalovirus in vitro elicits in concentrations 0.01-0.0005 μM and shows selectivity index 1 000-400 000.
EFFECT: valuable medicinal antiviral properties of compounds.
1 cl, 5 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING 9-[2-(4-ISOPROPYLPHENOXY)ETHYL])ADENINE | 2019 |
|
RU2714931C1 |
PYRIMIDINE DERIVATIVES OF BENZOPHENONE, HAVING ANTI-HIV-1 ACTIVITY | 2012 |
|
RU2489427C1 |
9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
USING POLYCARBOXYLIC FULLERENE DERIATIVE AS MICROBIOCIDAL ANTIVIRAL AGENT | 2012 |
|
RU2533232C2 |
METHOD FOR PRODUCING MONOSUBSTITUTED DERIVATIVES OF URACIL | 2017 |
|
RU2648998C1 |
5-SUBSTITUTED HIV-INHIBITING PYRIMIDINES | 2005 |
|
RU2410379C2 |
PHOSPHONATE DERIVATIVES | 2000 |
|
RU2258707C2 |
HIV-INHIBITING 2-(4-CYANOPHENYLAMINO)-PYRIMIDINE-OXIDE DERIVATIVES | 2006 |
|
RU2398768C2 |
INDASOLES, BENZISOXAZOLES AND BENZISOTIAZOLES, METHOD OF THEIR OBTAINING, PHARMACEUTICAL COMPOSITIONS AND APPLICATION AS ESTROGENIC MEDICATIONS | 2005 |
|
RU2402536C2 |
DERIVATIVES OF PIPERAZINE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF AND USING AS CCR5 ANTAGONISTS | 2000 |
|
RU2299206C9 |
Authors
Dates
2004-08-10—Published
2003-01-13—Filed